INVESTORS Events Details Global Hepatitis Summit 2023 Presentation - A gene editing approach for chronic hepatitis B: Elimination of hepatitis B virus in vivo by targeting cccDNA and integrated viral genomes with a sequence-specific ARCUS nuclease Apr 26, 2023 at 8:30 AM CEST Supporting Materials View Presentation 2.4 MB Investors Events & Presentations Press Releases Corporate Deck Stock Information Analyst Coverage SEC Filings Corporate Governance Investor FAQs Investor Tools Print Page Email Alerts Contact IR RSS Feeds
Global Hepatitis Summit 2023 Presentation - A gene editing approach for chronic hepatitis B: Elimination of hepatitis B virus in vivo by targeting cccDNA and integrated viral genomes with a sequence-specific ARCUS nuclease Apr 26, 2023 at 8:30 AM CEST Supporting Materials View Presentation 2.4 MB
